Glypressin Stungulyfsstofn og leysir, lausn 1 mg/hgl. Islandija - islandų - LYFJASTOFNUN (Icelandic Medicines Agency)

glypressin stungulyfsstofn og leysir, lausn 1 mg/hgl.

ferring lægemidler a/s - terlipressinum acetat - stungulyfsstofn og leysir, lausn - 1 mg/hgl.

Midazolam Medical Valley Munnholslausn 10 mg Islandija - islandų - LYFJASTOFNUN (Icelandic Medicines Agency)

midazolam medical valley munnholslausn 10 mg

medical valley invest ab - midazolamum hýdróklóríð - munnholslausn - 10 mg

Ondansetron Bluefish (Ondansetron BMM Pharma) Filmuhúðuð tafla 8 mg Islandija - islandų - LYFJASTOFNUN (Icelandic Medicines Agency)

ondansetron bluefish (ondansetron bmm pharma) filmuhúðuð tafla 8 mg

bluefish pharmaceuticals ab - ondansetronum hýdróklóríð - filmuhúðuð tafla - 8 mg

Ondansetron STADA Filmuhúðuð tafla 4 mg Islandija - islandų - LYFJASTOFNUN (Icelandic Medicines Agency)

ondansetron stada filmuhúðuð tafla 4 mg

stada arzneimittel ag - ondansetronum hýdróklóríð - filmuhúðuð tafla - 4 mg

Sotalol Viatris (Sotalol Mylan) Tafla 40 mg Islandija - islandų - LYFJASTOFNUN (Icelandic Medicines Agency)

sotalol viatris (sotalol mylan) tafla 40 mg

viatris limited - sotalolum hýdróklóríð - tafla - 40 mg

Sotalol Viatris (Sotalol Mylan) Tafla 80 mg Islandija - islandų - LYFJASTOFNUN (Icelandic Medicines Agency)

sotalol viatris (sotalol mylan) tafla 80 mg

viatris limited - sotalolum hýdróklóríð - tafla - 80 mg

Zofran Filmuhúðuð tafla 4 mg Islandija - islandų - LYFJASTOFNUN (Icelandic Medicines Agency)

zofran filmuhúðuð tafla 4 mg

sandoz a/s - ondansetronum hýdróklóríð - filmuhúðuð tafla - 4 mg

Zofran Filmuhúðuð tafla 8 mg Islandija - islandų - LYFJASTOFNUN (Icelandic Medicines Agency)

zofran filmuhúðuð tafla 8 mg

sandoz a/s - ondansetronum hýdróklóríð - filmuhúðuð tafla - 8 mg

Zofran Mixtúra, lausn 0,8 mg/ml Islandija - islandų - LYFJASTOFNUN (Icelandic Medicines Agency)

zofran mixtúra, lausn 0,8 mg/ml

sandoz a/s - ondansetronum hýdróklóríð - mixtúra, lausn - 0,8 mg/ml

Tygacil Europos Sąjunga - islandų - EMA (European Medicines Agency)

tygacil

pfizer europe ma eeig - tigecycline - bacterial infections; skin diseases, bacterial; soft tissue infections - sýklalyf fyrir almenn nota, - tygacil is indicated in adults and in children from the age of eight years for the treatment of the following infections: , complicated skin and soft tissue infections (cssti), excluding diabetic foot infections, complicated intra-abdominal infections (ciai) , tygacil should be used only in situations where other alternative antibiotics are not suitable. Íhuga ætti að opinbera leiðsögn á réttri notkun af sýklalyfjum. viðeigandi að nota af sýklalyfjum.